Skip to content

Zadek Osteotomy for Treatment of Haglund's Syndrome

Zadek Osteotomy for Treatment of Haglund's Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07157319
Enrollment
30
Registered
2025-09-05
Start date
2025-04-01
Completion date
2025-12-31
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haglund's Disease

Keywords

Zadek osteotomy for treatment of Haglund's syndrome

Brief summary

Haglund's syndrome is an abnormality of the bone and soft tissues in the foot. An enlargement of the bony section of the heel (where the Achilles tendon is inserted) triggers this condition. * symptom includes insertional Achilles tendinopathy (IAT), The patient with HS often has a red, irritated, painful heel. And they often complain the enlargement of the posterior heel, which make it more difficult to footwear or sport * Zadek described the Zadek Osteotomy option for the treatment of Haglund's syndrome This operation can change the calcaneus' anatomical length and elevate the distal insertion point of the Achilles tendon \- It is a prospective case series study that will be done in Orthopedics and Traumatology department of Sohag university hospitals on patients suffering from Haglund's syndrome and treated by Zadek osteotomy * This study aims to evaluate short term clinical, radiological and functional outcomes of Zadek osteotomy for treatment of Haglund's syndrome

Detailed description

Introduction * In 1928, Patrick Haglund described the Haglund syndrome firstly. Haglund's syndrome is an abnormality of the bone and soft tissues in the foot. An enlargement of the bony section of the heel (where the Achilles tendon is inserted) triggers this condition. The soft tissue near the back of the heel can become irritated when the large, bony lump rubs against rigid shoes. * symptom includes insertional Achilles tendinopathy (IAT), The patient with HS often has a red, irritated, painful heel. And they often complain the enlargement of the posterior heel, which make it more difficult to footwear or sport. * There are many conservative treatment options to treat it, which contains rest, activity modification, ice, or footwear modification. * When these treatment for more than 6 months has failed, surgical options will be considered. * Common surgical methods, including Haglund deformity debridement, endoscopic calcaneoplasty, and Zadek osteotomy (ZO). * Zadek described the ZO option for the treatment of HS firstly. It was later modified by Keck and ZO is a dorsal closing wedge calcaneal osteotomy that allows the tuberosity of Haglund deformity to be brought forward. This operation can change the calcaneus' anatomical length and elevate the distal insertion point of the AT. Aim of the work • This study aims to evaluate short term clinical, radiological and functional outcomes of Zadek osteotomy for treatment of Haglund's syndrome. Patients and Methods * It is a prospective case series study that will be done in Orthopedics and Traumatology department of Sohag university hospitals on patients suffering from Haglund's syndrome and treated by Zadek osteotomy * We are aiming in this study to include patients within period between 4/2025 to 10/2025

Interventions

None listed

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years

Inclusion criteria

* patients over 18 years of age and less than 60 Yrs * All patients had at least six months of conservative treatment

Exclusion criteria

1. patients below 18 years of age and more than 60 Yrs 2. patients of Haglund's syndrome with AT rupture or degeneration 3. uncontrolled diabetic patients with or without neuropathic joint destruction, 4. Infection such as osteomyelitis. 5. Charcot joint. 6. Peripheral vascular disease

Design outcomes

Primary

MeasureTime frameDescription
Primary outcomes for a Zadek osteotomy in Haglund's syndrome include: pain relief.From enrollment and follow up to the end of 24 weeks\- Pain Reduction: Marked improvement in pain, often measured by a Visual Analogue Scale (VAS) score, is a primary outcome, with significant reductions in pain intensity and frequency reported after the procedure.
functional improvement (measured by score VISA-A).From enrollment and follow up to the end of 24 weeksFunctional Improvement: VISA-A (Visual Analogue Scale for Achilles Tendinopathy) Score: A successful outcome is characterized by an improvement in the VISA-A score, reflecting better function for the Achilles tendon.
radiological changes to the calcaneusFrom enrollment and follow up to the end of 24 weekscalcaneal length and tuberosity ratio (X/Y Ratio): The osteotomy modifies the calcaneus by shortening it and rotating the posterosuperior tuberosity, which reduces impingement on the Achilles tendon. calcaneal pitch angle(calcaneal inclination angle): Studies have shown a reduction in the calcaneal pitch angle after Zadek osteotomy which is a relevant radiological parameter for Haglund's deformity
improved ankle motion (dorsiflexion),From enrollment and follow up to the end of 24 weeksImprovements in scores like the Tegner scale show a patient's ability to return to sports or other activities at a pre-injury level The Zadek osteotomy is known to improve the range of motion, specifically an increase in ankle dorsiflexion.
Patient Satisfaction:From enrollment and follow up to the end of 24 weeksHigh rates of patient satisfaction are a key indicator of a successful procedure, with many patients reporting positive experiences post-surgery

Countries

Egypt

Contacts

Primary ContactMohamed Kamal Abd Alhakeem Mohamed Kamal Abd Alhakeem, Orthopedics resident, Sohag Un
mo.hakeem2020@gmail.com+201550529605

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026